Ocular Therapeutix (NSDQ:OCUL) said today that its post-surgical ocular pain reliever, Dextenza, met both primary endpoints in a pivotal trial for the treatment of post-surgical ocular inflammation and pain. The product is a bioresorbable intracanalicular insert, designed for drug release to the ocular surface for up to 30 days. The randomized, double-masked study enrolled 438 patients who were […]
Pain Management
More deaths tied to Medtronic’s SynchroMed II drug pump
The SynchroMed II implantable drug pump was linked to more than 100 adverse events including 2 previously unreported deaths, Medtronic (NYSE:MDT) said last month. In a letter to doctors published yesterday by the U.K.’s Medicines & Healthcare Products Regulatory Agency, Fridley, Minn.-based Medtronic said the SynchroMed II pump can delivery too much medicine but that the exact case of […]
Doctors still order imaging for low back pain, against recommendations
(Reuters) — Many doctors who order CT or MRI scans for patients with low back pain do so fearing that patients will be upset if they do not get imaging and because there is too little time to explain the risks and benefits of the tests, a new study found. The Choosing Wisely campaign, launched by […]
U.S. Special Forces test Oska’s Pulse anti-pain device
Oska Wellness said today its Oska Pulse chronic pain management device is being tested by members U.S. Special Forces, specifically the Navy SEALS, with positive early results, the company said. The San Diego, Calif.-based company’s Oska Pulse device is designed to use pulsed electromagnetic field technology as a complement to physical therapy to help reduce […]
Relievant Medsystems raises $36m
Relievant Medsystems said today that it raised a $36 million equity round to support clinical trials for its Intracept intraosseous nerve ablation system. The Intracept system is designed to use radio frequency energy delivered through specially designed instruments during a minimally invasive surgical procedure to access and ablate the basivertebral nerve. The company touts the system as […]
Soterix Medical wins Health Canada approval, launches PainX tDCS
Soterix Medical said today it won Health Canada approval for and launched its PainX transcranial direct current stimulation technology designed for treating pain disorders in adults. The PainX tDCS system is a non-invasive, battery-powered device designed to deliver mild current to a specific section of the cerebral cortex to modulate reaction to painful experiences or control pain […]
NeuroMetrix launches Quell fybromyalgia pilot study
NeuroMetrix (NSDQ:NURO) said today it is launching a pilot study of its Quell wearable pain relief device for treating patients with fibromyalgia. Waltham, Mass.-based NeuroMetrix said it is partnering with the Synovation medical group to carry out the study. “We have seen both clinical data and positive reviews that suggest that Quell may be beneficial in […]
Theranica raises seed round for Nerivio Migra wearable migraine device
Newly-formed med device company Theranica Bio-Electronics said today it closed a seed financing round led by Dr. Shimon Eckhouse and joined by a group of angel investors. The company did not release the amount raised in the round. Israel-based Theranica is developing the Nerivio Migra, a disposable neuromodulation patch designed to treat migraine headaches. “Theranica […]
Nevro touts 2-year data on Senza spinal cord stim
Nevro Corp. (NYSE:NVRO) today released 2-year results from Senza-RCT study of its HF10 spinal cord stimulation system, touting superior results over low-frequency SCS therapy treatments. The Redwood City, Calif.-based company said results from the study were published in the journal Neurosurgery. Nevro said the trial is the largest prospective randomized trial of SCS systems and the […]
Bluewind Medical wins CE Mark for Vivendi mini-neurostim pain implant
Neurostim developer Bluewind Medical said today it won CE Mark approval in the European Union for its Vivendi neurostimulation device designed to treat peripheral neuropathic pain. The newly cleared neurostim device is 90% smaller than ‘typical’ neurostimulators on the market, the Israeli company said, and is designed to be implanted in close proximity to the Tibial […]
ElectroCore raises $1.5m
ElectroCore raised $1.5 million in a new round of debt financing, according to an SEC filing posted today. ElectroCore is developing a range of non-invasive vagus nerve stimulation for the treatment of a number of conditions in neurology, psychiatry, gastroenterology and other fields, according to the company’s website. Initial focus for the company is a […]